Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inwards

Showing results (271-280 of 382) with videos related to

Pageof 39
Sort By:
Leukemia & Lymphoma|October 27, 2006
The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin lymphomaIvana N M Micallef, Ellen D Remstein, Stephen M Ansell, et al.
Leukemia & Lymphoma|September 18, 2008
Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 yearsPankaj Malhotra, William J Hogan, Mark R Litzow, et al.
American Journal of Hematology|July 14, 2021
Lines of therapy before autologous stem cell transplant and CAR-T affect outcomes in aggressive Non-Hodgkin's lymphomaArushi Khurana, Matthew Hathcock, Thomas M Habermann, et al.
Haematologica|January 18, 2024
Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapyAung M Tun, Yucai Wang, Seth Maliske, et al.
Blood Cancer Journal|June 1, 2014
The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomasR Briski, A L Feldman, N G Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosisLuis F Porrata, Morie A Gertz, Mark R Litzow, et al.
Leukemia & Lymphoma|May 4, 2012
Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphomaLuis F Porrata, Kay Ristow, Thomas M Habermann, et al.
American Journal of Hematology|May 10, 2021
Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment eraNicholas J Boddicker, Melissa C Larson, Alessia Castellino, et al.
Leukemia & Lymphoma|September 25, 2014
Survival in patients with limited-stage peripheral T-cell lymphomasRobert Briski, Andrew L Feldman, Nathaniel G Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2010
Inhaled granulocyte-macrophage colony stimulating factor for first pulmonary recurrence of osteosarcoma: effects on disease-free survival and immunomodulation. a report from the Children's Oncology GroupCarola A S Arndt, Nadya V Koshkina, Carrie Y Inwards, et al.
Pageof 39

Showing results (271-280 of 382) with videos related to

Sort By:
Pageof 39
Leukemia & Lymphoma|October 27, 2006
The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin lymphomaIvana N M Micallef, Ellen D Remstein, Stephen M Ansell, et al.
Leukemia & Lymphoma|September 18, 2008
Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 yearsPankaj Malhotra, William J Hogan, Mark R Litzow, et al.
American Journal of Hematology|July 14, 2021
Lines of therapy before autologous stem cell transplant and CAR-T affect outcomes in aggressive Non-Hodgkin's lymphomaArushi Khurana, Matthew Hathcock, Thomas M Habermann, et al.
Haematologica|January 18, 2024
Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapyAung M Tun, Yucai Wang, Seth Maliske, et al.
Blood Cancer Journal|June 1, 2014
The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomasR Briski, A L Feldman, N G Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosisLuis F Porrata, Morie A Gertz, Mark R Litzow, et al.
Leukemia & Lymphoma|May 4, 2012
Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphomaLuis F Porrata, Kay Ristow, Thomas M Habermann, et al.
American Journal of Hematology|May 10, 2021
Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment eraNicholas J Boddicker, Melissa C Larson, Alessia Castellino, et al.
Leukemia & Lymphoma|September 25, 2014
Survival in patients with limited-stage peripheral T-cell lymphomasRobert Briski, Andrew L Feldman, Nathaniel G Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2010
Inhaled granulocyte-macrophage colony stimulating factor for first pulmonary recurrence of osteosarcoma: effects on disease-free survival and immunomodulation. a report from the Children's Oncology GroupCarola A S Arndt, Nadya V Koshkina, Carrie Y Inwards, et al.
Pageof 39